[Proglumetacin: a flexible and broad-spectrum antirheumatic agent].

Abstract

Fifty-five patients with osteoarthritis, rheumatoid arthritis or spondyloarthritis, joint pain and other rheumatic-inflammatory disorders were treated with proglumetacin, at different doses, during 3-60 days. Assessment of therapeutic efficacy indicated 88.9% of good results. Joint pain progressively decreased during the whole period of observation. Tolerance was considered good or very good in 78% of patients.

• Authors: G Fontanesi, F Giancecchi, R Rotini, I Tartaglia
• Journal: Minerva medica (Minerva Med) Vol. 74 Issue 26 Pg. 1547-51 (Jun 23 1983) ISSN: 0026-4806 [Print] Italy
• Vernacular Title: Proglumetacina: antireumatico flessibile e ad ampio spettro.
• PMID: 6602308 (Publication Type: English Abstract, Journal Article)

Chemical References

• Indoleacetic Acids
• proglumetacin

Topics

• Adolescent
• Adult
• Aged
• Arthritis, Rheumatoid (drug therapy)
• Child
• Drug Evaluation
• Drug Tolerance
• Female
• Humans
• Indoleacetic Acids (therapeutic use)
• Male
• Middle Aged
• Osteoarthritis (drug therapy)
• Pain (drug therapy)
• Periarthritis (drug therapy)
• Rheumatic Diseases (drug therapy)
• Spondylitis (drug therapy)